Genmab A (GMAB) Capital Expenditures (2024 - 2025)
Genmab A's (GMAB) quarterly Capital Expenditures came in at $22.0 million in Q2 2025, up 175.0% YoY from $8.0 million in Q2 2024, and up 175.0% on a QoQ basis from $8.0 million in Q2 2024.
Genmab A (GMAB) Capital Expenditures (2024 - 2025) Analysis & Trends
Genmab A (GMAB) has 2 years of Capital Expenditures data on file, last reported at $22.0 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 112.20 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 240.20 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 2.29 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 25.02 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 572,662.23 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 251.02 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 34.68 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 6.26 Mn |
| 10 | Genmab A | 2.05 Bn | 548.77 Mn | 1.07 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 22.00 Mn |
| Jun 30, 2025 | 22.00 Mn |
| Jun 30, 2024 | 8.00 Mn |
| Jun 30, 2024 | 8.00 Mn |